Biomapas Academy Alumni 

How to become a life sciences specialist?

Thinking about joining? Experience the academy through the alumni.

Every year, we select a limited number of applicants to become part of the Biomapas Academy, where they learn about Clinical Research, Regulatory Affairs and Pharmacovigilance. From theory to practice, we seek to answer all questions and lead young professionals into their careers.

Explore the experiences of our past students and how the academy impacted their professional journey afterwards. Read some success stories of newfound passions, changes in job fields, expanded understanding of the life sciences industry, and even completed internships.

The CIS Region: Excellent Potential for Patient Recruitment but is there any Risk to Quality?

The CIS Region: Excellent Potential for Patient Recruitment but is there any Risk to Quality?

The number of clinical trials worldwide is increasing more than 10% each year due to the new diseases, further research for better health products and development of new drugs. Though, for a successful clinical trial, there is a major challenge – patient recruitment, which is essential and the most challenging factor due to the increasing number of new clinical trials. In order to achieve the required patient recruitment, sponsors are looking for different solutions.

read more
The Predicted Impact of the ISO IDMP Standards Implementation Process Carried Out by the European Medicines Agency

The Predicted Impact of the ISO IDMP Standards Implementation Process Carried Out by the European Medicines Agency

The IDMP is a general term by which the 5 ISO data standards are referenced: ISO 11615 (regulated medicinal product information), ISO 11616 (regulated pharmaceutical product information), ISO 11238 (substances), ISO 11239 (pharmaceutical dose forms, units of presentation, routes of administration and packaging) and ISO 11240 (units of measurement). – which are being refined and implemented by regulatory bodies.

read more
Running a clinical trial in the Baltic states

Running a clinical trial in the Baltic states

In the past five years, an average of 175 clinical trials are being initiated in the Baltic states each year. An average of 64,8% of the population in the Baltic states are in the age from 15 to 65 years old, the main target audience for clinical trials. Furthermore, a large pool of treatment-naïve subjects is available compared to other EU countries or the US. Patients with special therapeutic diseases are transferred to the main central hospitals.

read more
Falsified Medicines Directive Implementation – Marketing Authorization Holder Perspective

Falsified Medicines Directive Implementation – Marketing Authorization Holder Perspective

Falsified Medicines Directive (FMD) 2011/62/EU which aims to increase the security of manufacturing and delivery of medicines across Europe as well as protect patients and prevent falsified medicines from entering the supply chain has come in force Feb 9th, 2019. With the first quarter almost over, it is a great opportunity to look back and share the experience. The new requirements for safety features to appear on the packaging of all prescription medicines.

read more
Biomapas appoints Chief Financial Officer

Biomapas appoints Chief Financial Officer

Filip Risteski was recently appointed as Chief Financial Officer (CFO) at Biomapas and will be one of the key players further strengthening continued growth of Biomapas. Filip will report directly to Audrius Sveikata, Biomapas Chief Executive Officer. As a CFO he will be responsible for placing control over finance function and financial strategy, by maximizing efficiency and ensuring highest quality standards. Furthermore, Filip will work with a management team on implementation of overall company business strategy.

read more
Remaining Vigilant and Compliant after Brexit: What’s next? (Latest Updates)

Remaining Vigilant and Compliant after Brexit: What’s next? (Latest Updates)

On 29th March 2017 UK submitted the notification of its intention to withdraw from the EU. This means that UK will become a ‘third country’ from 30th March’19. Even though leaving the EU with a deal remains the Government’s top priority, UK drug agency is publishing a series of guidance documents for industry and other stakeholders covering the proposed arrangements for the regulation of medicines, medical devices and clinical trials, if UK leaves EU with no deal.

read more
Implementation of ISO 9001 and 13485 standards: what does it bring to company and clients?

Implementation of ISO 9001 and 13485 standards: what does it bring to company and clients?

Compliance with high quality standards is a non-negotiable performance parameter in Pharmaceutical and Medical Device industries. During 2016, Biomapas was re-certified according to the newest ISO 9001 standard version. Moreover, at the beginning of 2017, ISO 13485 implementation into BIOMAPAS Quality Management System was initiated. We discussed the influence of current changes to the whole company and its quality management with Egidija Pauriene, MD, Quality Assurance Director.

read more
Changing regulatory environment: eCTD submissions to become obligatory as of 2018

Changing regulatory environment: eCTD submissions to become obligatory as of 2018

A new challenge is about to be faced by the MAHs of medicinal products. Since online tools are becoming a bigger part of our daily lives, the competent authorities are also moving forward step by step. 1st Jan 2018, the European Medicines Agency will require that all regulatory submissions for medicinal products authorized via Decentralized or Mutual Recognition Procedure will be provided in eCTD format.

read more
Tuberculosis Medicines Clinical Development in Eastern Europe and CIS

Tuberculosis Medicines Clinical Development in Eastern Europe and CIS

World Tuberculosis Day is commemorated every year on 24th March to raise awareness of tuberculosis, which is still causing death of nearly 1.5 million people each year, mostly in developing countries. It marks the day in 1882, when Dr. Robert Koch announced that he had discovered the cause of tuberculosis, the TB bacillus. In comparison to other infectious diseases caused by a single infectious agent, tuberculosis is the second biggest killer worldwide.

read more

Biomapas announces the opening of a new office in Sweden

Biomapas has recently announced the opening of a new office in Stockholm, Sweden. This new location strengthens Biomapas’ presence in the Nordic countries and further accommodates the rapid growth of the company.

The expansion into the Nordics is in direct response to demand from Biomapas clients seeking local Regulatory and Pharmacovigilance support. The company already has offices in Switzerland, Lithuania, Russia, Georgia and Ukraine.

read more
Harmonization of EAEU GVP: CIS is getting more vigilant than ever before

Harmonization of EAEU GVP: CIS is getting more vigilant than ever before

On the 6-7 March, Biomapas Pharmacovigilance Department management and team from the CIS region participated in a meeting in Minsk. It was dedicated to strengthening collaboration between the team members as well as updating knowledge on latest PV trends. We discussed the most recent releases of legislation, such as Eurasian Economic Union Good Pharmacovigilance Practice harmonization and the importance of a teamwork approach with Biomapas’ PV Project Manager CIS, Aliaksandr Bakshtanovich, MD.

read more

European Union Funding

In July 2020 Biomapas started an EU funded project of research and development activities by creating an artificial intelligence (AI) tool for pharmacovigilance services.

read more

Biomapas receives Knowledge Economy Company 2016 award

26th January, 2016 Biomapas representatives attended the Knowledge Economy Forum award ceremony at the Presidential Palace of the Republic of Lithuania. The Knowledge Economy Company awards are granted each year from 2004 in order to honor the most progressive and innovative companies operating in Lithuania, creating high value-added products or services. The awards are patronized by the President of the Republic of Lithuania Dalia Grybauskaitė.

read more

Bridging The Gap.

From Academy To Industry.

Paulina P. Biomapas Academy

What set this experience apart was not just the theoretical knowledge but also the opportunity to learn firsthand from industry professionals, gaining insights into their daily routines and witnessing their genuine passion for clinical research. I am grateful to everyone who poured their hard work into this project, and I feel honored to have been a part of it. To those considering participation, I wholeheartedly encourage you not to hesitate. Embrace the opportunity, as you may discover, as I did, a newfound passion within the realm of clinical research.

Paulina Pupalė

Gabriele J. Biomapas Academy

I am glad that I got the opportunity to broaden my knowledge of clinical trials, regulatory affairs and pharmacovigilance from professionals in these fields. During the academy, you will obtain not just a huge amount of information but also remarkable friendships and connections, which could be beneficial in the future.

Gabrielė Juraitytė

Aurimas P. Biomapas Academy

Attending the Biomapas Academy was an enriching experience that surpassed my expectations. The lectures were comprehensive and well-presented, providing a thorough understanding of pharmacovigilance and regulatory affairs. The organizational aspect of the Academy was exemplary, with clear and comprehensive communication.

Aurimas Plaga

Ineta M. Biomapas Academy

Biomapas Academy broadens horizons and introduces clinical research very widely, as well as pharmacovigilance and regulatory affairs. After this academy, it’s much clearer and easier to understand what happens behind the closed doors of pharma.

Ineta Meldaikytė

Karolina K Biomapas Academy

Biomapas Academy is an educational program that connects participants with industry experts, offering practical insights in an engaging manner. I highly recommend it to those who want to explore a career in life sciences.

Karolina Koškinaitė

Monika B. Biomapas Academy

I came to know more about what interests me – the drug industry, and left with a clear mind where exactly I want to stand in this field.

Monika Bertašiūtė

Emilja G. Biomapas Academy

In this Academy, I truly broadened my knowledge of life sciences. Also, I should mention the people, the kind lecturers and the Biomapas staff; I even became friends with other participants!

Emilija Galkutė

Augustinas Drapeko

It was an amazing experience to learn and network with people with such passion for furthering the healthcare industry. I have found my passion towards the clinical trials and pharmacovigilance industry, which would not have been possible without the knowledge I gained from this academy. Forever grateful for this opportunity, and I highly recommend this academy to those who wanna learn and grow in their respective careers!

Rakshana Alexander

Academy student - Katarzyna Gancarz

I am very happy that I decided to attend this Academy. Here, I learned a lot of useful and interesting information, which allowed me to get a very clear picture of where I can further realize myself. I highly recommend this Academy to all young professionals who are still looking for themselves and don’t know which way to go next.

Gabrielė Juknevičiūtė

Academy student - Livija Skėrytė

I am grateful for the opportunity to attend Biomapas Academy. It definitely broadened my horizons in the pharmaceutical industry field. Even if you don’t plan to work in a CRO company, but you are interested in drug development, give Biomapas Academy a try; it is definitely worth the time and effort.

Guoda Pranaitytė

Academy student - Katarzyna Gancarz

It gives guidance in the complex and strictly regulated pharma&biotech field by delivering high-quality, well-designed lectures provided by engaging professionals. Joining the Academy is the simplest way to open the door to new career paths.

Rugilė Norvaišaitė

Academy student - Livija Skėrytė

It is much easier to understand what kind of field is interesting for you. Another boon of the Academy is the familiarization with the main terminology used in this type of environment, which establishes a foundation and prepares you for working in such an industry.

Gabrielius Stankus

Academy student - Katarzyna Gancarz

If you keep considering what career path might be the best for you, I advise you not to doubt and apply to the Biomapas Academy. This is a fun, risk-free way to try the industry out and see if it’s the right fit for you.

Lina Radvilaitė

Academy student - Livija Skėrytė

Biomapas Academy is a well-structured and comprehensive training program that provides valuable knowledge and practical skills for individuals interested in the pharmaceutical industry and clinical researches.

Tea Lobjanidze

Augustinas Drapeko

You may know a lot about various specific things or processes related to pharmaceuticals, but at this Academy, everything was laid out in such a clear and detailed way that you realize how much lies beyond your knowledge. It was wonderful to meet so many young, talented, and passionate professionals in their fields. Their lectures and knowledge ignited my curiosity even more, and I desire one day to become one of them.

Roberta Labokienė

Academy student - Katarzyna Gancarz

I confirm that Biomapas Academy is an excellent choice not only for someone who wants to start a career in the industry, but also for someone who is looking for a further path to valuable, solid self-development in the life science sector. I also met fantastic, motivated people. Highly recommended!

Katarzyna Gancarz

Academy student - Livija Skėrytė

I am really thankful that I had a chance to participate at Biomapas Academy. Getting the detailed information really broadened my horizons, and new connections that I made I hope will be lifelong. No doubt it was an extraordinary journey, and I wish for all the future participants to have fun just as I did.

Livija Skėrytė

Ineta Chochlovaitė

I am very grateful that I had an opportunity to participate in the Biomapas Academy. During my time in the Academy, I gained knowledge in clinical research, pharmacovigilance, regulatory affairs, and met incredible people. I feel this experience will be very beneficial for future career opportunities.

Ineta Chochlovaitė

Faez Mujeebu Rahman

 I must say I’ve got more than what I bargained for. Each lecture provided new information which enlightened me. It was definitely a fun ride. Each topic and lecturer was very well presented . I thoroughly enjoyed this journey and I hope more people give Biomapas a try.

Faez Mujeebu Rahman

I was really thrilled to be a participant in the Biomapas Academy. It was a great experience for me and a chance to learn from professionals. Many thanks to the Biomapas Team for their effort in preparing such insightful lectures.

Agnieszka Sosnicka

I truly believe that the knowledge and experience I have gained will help me grow professionally and expand new career opportunities. I really enjoyed this great Academy’s time. Thanks to the Biomapas team and lecturers who were always willing to answer all questions.

Aistė Butkevičiūtė

Augustinas Drapeko

Participating in the academy was a thrill! I learned a lot and I am positive that the knowledge I gained will help my professional future. All of the topics were presented very clearly and I found that all of the information was incredibly useful for someone pursuing the health science industry. I am incredibly grateful for the opportunity to join the Academy and broaden my knowledge of the complex pharmaceutical industry!

Augustinas Drapeko

I am very grateful for having an opportunity to meet lots of different students from other countries, learning a lot from every one of them. Biomapas Academy is a great thing that really changed my understanding of clinical trials. Thank you!

Anastasiia Moisieienko

The pharmaceutical industry is highly complex and strictly regulated. Therefore, learning directly from the passionate field professionals was an invaluable experience. I think it will be extremely useful for career mobility in the future.

Audronė Čibiraitė

Biomapas Academy was a very beneficial experience – only useful information given in a nutshell. I also could count on the immediate support and ask questions even a few weeks later. I recommend Biomapas Academy for all students and graduates who want to start their journey.

Dawid Skoczek

Biomapas Academy has undoubtedly been a great experience. I had a wonderful chance to learn from many experienced professionals and gain knowledge in different fields of the pharmaceutical industry. Surely, it will be very useful considering further developments in my career.

Ieva Lenkaitė

Studying at the Biomapas Academy allows you to expand your knowledge with research, product development, distribution, safety worldwide. The best professionals have opened the international level of pharmacological research for us. The course is very interesting and rich.

Lena Kovalchuk

I’m glad to say that this experience exceeded my expectations. To be able to learn about clinical operations, regulatory affairs and pharmacovigilance from experienced professionals is truly a unique opportunity. I am certain it will prove useful in our future careers.

Rimantė Čirvinskaitė

When I saw a post on social media about a possibility to take place in the Biomapas Academy, I signed up for it without hesitation. I was sincerely thrilled after I found out that I was selected to be one of the participants! I always desired to learn more about clinical trials, pharmacovigilance, regulatory affairs and discover my potential career opportunities.

The Biomapas Academy fulfilled what I was looking for and gave me even more. It most definitely pointed out to me where I should focus my attention to accomplish what I truly hope to. After graduating from the Academy, I can strongly advice you to participate and gain valuable knowledge and experience from many professionals. Thanks to the Biomapas team and lecturers who were always willing to help and answer all the questions!

Simona Petrauskaitė

Great chance and a lot of knowledge – this is Biomapas Academy! Learning from experienced professionals is a good opportunity to develop skills. A lot of information about Clinical Operations, Pharmacovigilance and Regulatory Affairs. I recommend it to everyone!

Magdalena Romanska

With each lecture, I became more and more motivated to gain new knowledge and delve deeper into the topics. I hope the knowledge provided by qualified specialists will be useful in the future because this project led me to take an interest in career opportunities in these fields.

Milda Bulotaitė

It’s a new way of getting more information about different pharmaceutical domains that range from research and innovation, product development, production and distribution of drug products and indeed advancement and support of healthcare directly from the members of Biomapas.

Ieva Bagdanavičiūtė

Biomapas Academy is my discovery this year. I am so happy that I could join it and meet such interesting people. I feel that all my studies have not gone in vain, and I want to expand further and adapt my knowledge and experience.

Daiva Staradumskytė

Biomapas academy has been a great experience. The academy lecturers were well prepared and were always willing to answer all questions. I got to know a lot about the pharmaceutical industry, but also I have had a great, useful and enriching time.

Austėja Šalvytė

The experience I have gained allowed me to see and learn the other side of pharma, to get to know professionals in this field who share their work experience – for this, I am very grateful. Thanks to the entire Biomapas team for this short but memorable period together.

Roberta Dagilienė

Biomapas Academy

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information